ORIENT BIO Inc. (002630.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 68.54B |
| Enterprise Value | 64.65B |
| P/E Ratio | -11.02 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 1.69 |
| Price/Book Ratio | 0.73 |
| Enterprise/Revenue | 1.55 |
| Enterprise/EBITDA | -22.24 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.15 |
| Operating Margin | -0.15 |
AD
Management Effectiveness
| Return On Assets | -0.06 |
| Return On Equity | -0.07 |
Income Statement
| Revenue | 29.75B |
| Revenue/Share | 501.83 |
| Gross Profit | 3.96B |
| EBITDA | -2.24B |
| Net Income | -4.57B |
| Diluted EPS | -77.03 |
Balance Sheet
| Total Cash | 32.77B |
| Total Cash/Share | 552.74 |
| Total Debt | 1.94B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 7.82 |
| Book Value Per Share | 1,156.05 |
Price History
| 52-Week Change | -43.07 |
| 52-Week High | 1,632 |
| 52-Week Low | 745 |
| Moving Average 50 Days | 935.46 |
| Moving Average 200 Days | 1,106.21 |
Statistics
| Average Volume | 314,603 |
| Shares Outstanding | 59.29M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
| Last Split Date | June 09, 2026 |
AD
